Intelligent Bio Solutions (INBS) Share-based Compensation (2024)
Intelligent Bio Solutions' quarterly Share-based Compensation came in at $12000.0 in Q4 2024, down 94.06% quarter-over-quarter from $202045.0 in Q3 2024.
Intelligent Bio Solutions has reported Share-based Compensation for 1 years, with the latest figure at $12000.0 in Q4 2024.
- For the quarter ending Q4 2024, Share-based Compensation changed N/A year-over-year to $12000.0; the trailing twelve-month figure through Mar 2025 stood at $214045.0 (changed N/A YoY), and the FY2023 full-year result was $260000.0, changed N/A from the prior year.
- Share-based Compensation for Q4 2024 stood at $12000.0, down from $202045.0 in the prior quarter.
- The five-year high for Share-based Compensation was $202045.0 in Q3 2024, with the low at $12000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 202,045.00 |
| Sep 30, 2024 | 202,045.00 |